StartATBPF • OTCMKTS
add
Antibe Therapeutics Ord Shs
Seneste lukkekurs
0,22 $
Årsinterval
0,11 $ - 0,89 $
Gns. volumen
27,54 t
P/E-værdi
-
Udbytteprocent
-
Markedsnyheder
Økonomi
Resultatopgørelse
Indtægt
Nettoindtægt
| (CAD) | dec. 2023info | År til år-ændring |
|---|---|---|
Indtægt | — | — |
Driftsudgifter | 4,60 mio. | -1,42 % |
Nettoindtægt | -4,21 mio. | 2,39 % |
Overskudsgrad | — | — |
Earnings per share | -0,08 | 0,50 % |
EBITDA | — | — |
Effektiv afgiftssats | — | — |
Årsbalance
Samlede aktiver
Samlede passiver
| (CAD) | dec. 2023info | År til år-ændring |
|---|---|---|
Kontanter og korttidsinvesteringer | 24,91 mio. | -41,20 % |
Samlede aktiver | 56,36 mio. | -23,56 % |
Samlede passiver | 30,42 mio. | -0,13 % |
Samlet egenkapital | 25,94 mio. | — |
Shares outstanding | 52,67 mio. | — |
Kurs/indre værdi | 0,44 | — |
Afkast af aktiver | -19,71 % | — |
Afkast af kapital | -41,30 % | — |
Pengestrøm
Nettoændring i likviditet
| (CAD) | dec. 2023info | År til år-ændring |
|---|---|---|
Nettoindtægt | -4,21 mio. | 2,39 % |
Pengestrøm fra drift | -3,84 mio. | -6,66 % |
Pengestrøm fra investering | 11,04 mio. | 1.975,38 % |
Pengestrøm fra finansiering | — | — |
Nettoændring i likviditet | 7,20 mio. | 334,09 % |
Fri pengestrøm | -2,47 mio. | -2.419,13 % |
Om
Antibe Therapeutics was a Toronto-based pharmaceutical company that develops pain and inflammation-reducing drugs based on gaseous mediator technology. Antibe was founded by John L. Wallace, also a co-founder of NicOx, the first company to develop drugs utilizing gaseous mediators. Founded in 2009, the company listed on the TSX Venture Exchange in 2013 and was moved to the Toronto Stock Exchange in November 2020. In 2015, Antibe acquired Citagenix, a distributor involved in regenerative medicine.
On June 1, 2020, the company announced positive results in the final Phase 2 trial of its first drug Otenaproxesul.
On March 29, 2021, the drug's Investigational New Drug application was cleared by the US Food and Drug Administration, allowing for human trials.
In May 2024 the company went bankrupt and its stock was delisted from the Toronto Stock Exchange. Wikipedia
Grundlagt
2009
Website
Ansatte
11
